Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cisplatin (platinol) (1 trial)
immuvac (1 trial)
paclitaxel (taxol) (1 trial)
riviciclib (2 trials)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Lung Neoplasms (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Trials (3 total)
Trial APIs (4 total)